Counterfeit pharmaceutical drugs

In a study on “Trends in trade with counterfeit and pirated goods” conducted by the European Union Intellectual Property Office and the Organisation for Economic Co-operation and…

Continue Reading Counterfeit pharmaceutical drugs
Update Ed. 1/2020

Our „Update“ contains among others some news articles: Artificial intelligence as inventor -- The printed copy at the EPO -- The figurative trademark „BREXIT“ -- Rubik’s cube…

Continue Reading Update Ed. 1/2020
Latest Brexit Information

February 2020 1. Transition period The United Kingdom departed the EU on 31 January 2020. The withdrawal agreement now provides for a transition period until 31 December…

Continue Reading Latest Brexit Information
Artificial intelligence as inventor

At present, the “patent world” is dealing with decisions of receiving offices responsible for the formal examination of patent applications, which reject patent applications in which an…

Continue Reading Artificial intelligence as inventor
The printed copy at the EPO

The importance of the so-called "printed copy" in the context of the Communication under Rule 71(3) EPC was recently confirmed by a Technical Board of Appeal of…

Continue Reading The printed copy at the EPO
G1/19: Simulation process

In a current case, the Enlarged Board of Appeal is supposed to create new jurisdiction with respect to computer implemented simulation processes. The case The case at…

Continue Reading G1/19: Simulation process
Haar or Munich (G 2/19)

The Technical Board of Appeal 3.5.03 had to deal with an obviously illegitimate appeal. In this appeal, an appellant filed third party observations in the prosecution procedure…

Continue Reading Haar or Munich (G 2/19)
Update Ed. 2/2018

Important strategic contemplations for owners of European patentsPreliminary remuneration of employee inventorTo what extent does a patent owner have to accept his own former statementsagainst himself in…

Continue Reading Update Ed. 2/2018